Some estimated factors from the model
Effect of gender, age and physician prescribed high amount of BZD | ||||||
To level | Gender | Age | FBZDP | |||
1 | −0.008 (ns) | 0.006 | 0.040 | |||
2 | −0.146 | 0.007 | 0.262 | |||
3 | −0.552 | −0.021 | 0.127 | |||
Effect of first drug choice (compared to diazepam) | ||||||
Oxazepam | Alprazolam | Nitrazepam/flunitrazepam | Zopilone/zolpidem | Hydroxyzine/buspirone | ||
1 | 0.146 | 0.014 (ns) | −0.046 | 0.032 | −0.200 | |
2 | 0.167 | 0.165 (ns) | 0.515 | 0.465 | −0.168 | |
3 | 0.204 | −0.010 (ns) | 0.375 | 0.063 (ns) | −0.230 (ns) | |
Effect of other drugs | ||||||
Opioids/antialcohol/smoke cessation | Antidepressants/lithium | Antipsychotics | Antiasthmatics/COPD drugs | Cardiac drugs | Methotrexate/steroids | |
1 | 0.136 | 0.214 | 0.152 | 0.100 | 0.030 | 0.035 |
2 | 0.272 | 0.280 | 0.398 | 0.146 | 0.090 | 0.249 |
3 | 0.738 | 0.334 | 0.570 | 0.266 | 0.002 (ns) | 0.194 (ns) |
Effect of prescribers specialty (compared to no specialty) | ||||||
General practitioner | Internist | Psychiatrist | Surgeon | Another specialty | ||
1 | 0.017 | −0.108 | −0.054 | −0.136 | −0.043 | |
2 | −0.048 | 0.200 | 0.178 | 0.003 (ns) | 0.003 (ns) | |
3 | −0.152 | 0.066 (ns) | −0.013 (ns) | −0.119 (ns) | −0.042 (ns) |
ns indicates not significant, 5% level.
BZD, Benzodiazepine; COPD, chronic obstructive pulmonary disease; FBZDP, Frequent BZD prescriber